Defective Single-Site Nanozymes with Exposed Unsaturated Cu–N 2 Sites for Antitumor Immunotherapy via Innate Immune-Checkpoint Blockade
Journal of the American Chemical Society · 11.03.2026 · 148 (9) · 9277-9295
DOI: 10.1021/jacs.5c13802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.02.2026. Verfasst von Yang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, 637371, Singapore. Hauptthemen laut MEDLINE: Copper, Antineoplastic Agents, Immunotherapy, Immunity, Innate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Research Foundation Singapore, National Natural Science Foundation of China.
Abstract (Originalsprache)
Disrupting the redox balance of tumor cells while blocking MER proto-oncogene tyrosine kinase (MerTK)-mediated macrophage efferocytosis can simultaneously awaken and enhance innate and adaptive antitumor immunity. Herein, we develop an MRX-2843 (MerTK inhibitor) and Mn2+ codelivered defective metal-organic framework (copper-2,3,6,7,10,11-hexaiminotriphenylene (Cu-HITP))-based single-site nanozyme (Ir@D-Cu-HITP-MMP) for antitumor immunotherapy via innate immune-checkpoint blockade. Highly exposed unsaturated Cu-N2 sites feature asymmetric electron distribution, inducing localized electron polarization and exhibiting excellent enzyme-like catalytic performance for reactive oxygen species (ROS) generation. The ROS surge disrupts redox homeostasis, impairing mitochondrial function and adenosine triphosphate production, while affecting copper transport for cuproptosis and suppressing heat shock protein expression to facilitate mild photothermal therapy. Furthermore, the tumor microenvironment-triggered release of MRX-2843 inhibits macrophage efferocytosis, increasing tumor immunogenicity and promoting prolonged cyclic GMP-AMP (cGAMP) transport. This synergizes with Mn2+ to enhance the stimulator of interferon genes (STING) activation, triggering robust immune responses. Overall, Ir@D-Cu-HITP-MMP demonstrates potent antitumor effects by activating powerful innate and adaptive immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, 637371, Singapore.
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
- Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China.
ORCID-Profile: Yang Liu, Shuai Bi, Shuyan Song, Yinghui Wang, Hongjie Zhang, Yanli Zhao
Förderung
- National Research Foundation Singapore
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Zhao, H., Niu, R., Zhang, B., Bi, S., Song, S., Wang, Y., Zhang, H., & Zhao, Y. (2026). Defective Single-Site Nanozymes with Exposed Unsaturated Cu–N 2 Sites for Antitumor Immunotherapy via Innate Immune-Checkpoint Blockade. Journal of the American Chemical Society, 148(9), 9277-9295. https://doi.org/10.1021/jacs.5c13802
Vancouver
Liu Y, Zhao H, Niu R, Zhang B, Bi S, Song S, et al. Defective Single-Site Nanozymes with Exposed Unsaturated Cu–N 2 Sites for Antitumor Immunotherapy via Innate Immune-Checkpoint Blockade. Journal of the American Chemical Society. 2026;148(9):9277-9295. doi:10.1021/jacs.5c13802
BibTeX
@article{Liu2026,
author = {Liu, Yang and Zhao, Huan and Niu, Rui and Zhang, Bin and Bi, Shuai and Song, Shuyan and Wang, Yinghui and Zhang, Hongjie and Zhao, Yanli},
title = {Defective Single-Site Nanozymes with Exposed Unsaturated Cu–N 2 Sites for Antitumor Immunotherapy via Innate Immune-Checkpoint Blockade},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {9},
pages = {9277--9295},
doi = {10.1021/jacs.5c13802}
}
EUVIMED